SEI Investments
KPTI icon

SEI Investments’s Karyopharm Therapeutics KPTI Stock Holding History

SEI Investments’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,667
Closed -$34.7K – 2729
2024
Q2 		$34.7K Hold
2,667
– – ﹤0.01% 2611
2024
Q1 		$60.4K Buy
+2,667
New +$46.8K ﹤0.01% 2551
2021
Q3 		– Sell
-2,054
Closed -$314K – 2599
2021
Q2 		$314K Sell
2,054
-166
-7% -$24.1K ﹤0.01% 2293
2021
Q1 		$350K Sell
2,220
-94
-4% -$19.8K ﹤0.01% 2189
2020
Q4 		$532K Sell
2,314
-45
-2% -$10.4K ﹤0.01% 1948
2020
Q3 		$515K Sell
2,359
-76
-3% -$18.6K ﹤0.01% 1880
2020
Q2 		$691K Sell
2,435
-1,335
-35% -$395K ﹤0.01% 1717
2020
Q1 		$1.08M Buy
3,770
+572
+18% +$158K ﹤0.01% 1430
2019
Q4 		$919K Buy
3,198
+2,033
+175% +$441K ﹤0.01% 1673
2019
Q3 		$168K Buy
+1,165
New +$158K ﹤0.01% 2267

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

SEI Investments's KPTI Position: Q3 2024 in Review

SEI Investments sold out of Karyopharm Therapeutics (KPTI) in Q3 2024, closing a stake of 2,667 shares — an estimated $34.7K sold.

SEI Investments first reported a position in KPTI in Q3 2019 and held it in 10 quarters. The position peaked at $1.08M in Q1 2020. 91 funds tracked by Wall St. Rank hold KPTI as of Q3 2024.

  • SEI Investments reported no remaining Karyopharm Therapeutics position as of Q3 2024 after selling out during the quarter.
  • SEI Investments sold 2,667 Karyopharm Therapeutics shares in Q3 2024, an estimated $34.7K.
  • SEI Investments first reported a position in Karyopharm Therapeutics in Q3 2019 and held it in 10 quarters.
  • SEI Investments's Karyopharm Therapeutics position peaked at $1.08M in Q1 2020.
  • 91 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2024.

Based on SEI Investments's 13F filing for Q3 2024, filed 12 Nov 2024.